Panretinal Photocoagulation Versus Ranibizumab for Proliferative Diabetic Retinopathy: Patient-Centered Outcomes From a Randomized Clinical Trial

We read with interest the article by Beaulieu and colleagues1 regarding patient-centered outcomes in the treatment of proliferative diabetic retinopathy (PDR). Both proliferative and advanced nonproliferative retinopathy may cause significant loss of peripheral vision and visual acuity (particularly in dim light situations or night driving). New therapeutic options are available to treat and effectively manage diabetic retinopathy and help enhance quality of life.2 However, aggressive use of modern treatment for diabetic retinopathy potentially would improve vision in most patients, but it is a challenge that many patients still do not achieve reading and driving vision.
Source: American Journal of Ophthalmology - Category: Opthalmology Authors: Tags: Correspondence Source Type: research